Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Blondel

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Pathology|September 5, 2014
Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancersChrysoula Daskalogianni, Slovénie Pyndiah, Sébastien Apcher, et al.
RNA (New York, N.Y.)|September 16, 2025
The codon context provides <i>cis</i>-acting immune evasion for the human papilloma virus (HPV) E6Aikaterini Thermou, Chrysoula Daskalogianni, Lixiao Wang, et al.
Genes|September 5, 2019
Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune EvasionGaëlle Angrand, Alicia Quillévéré, Nadège Loaëc, et al.
Nucleic Acids Research|January 10, 2019
Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptidesRodrigo Prado Martins, Laurence Malbert-Colas, María José Lista, et al.
Disease Models & Mechanisms|January 20, 2019
A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defectsThomas Delerue, Déborah Tribouillard-Tanvier, Marlène Daloyau, et al.
Plos One|April 24, 2008
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prionsDéborah Tribouillard-Tanvier, Vincent Béringue, Nathalie Desban, et al.
The Journal of Biological Chemistry|May 16, 2013
The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competitionYanhong Pang, Sriram Kurella, Cécile Voisset, et al.
Nature Biotechnology|August 12, 2003
Isolation of drugs active against mammalian prions using a yeast-based screening assayStéphane Bach, Nicolas Talarek, Thibault Andrieu, et al.
Microbial Cell (Graz, Austria)|September 16, 2017
A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthinessMaría José Lista, Rodrigo Prado Martins, Gaelle Angrand, et al.
Disease Models & Mechanisms|February 22, 2014
A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virusCécile Voisset, Chrysoula Daskalogianni, Marie-Astrid Contesse, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Pathology|September 5, 2014
Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancersChrysoula Daskalogianni, Slovénie Pyndiah, Sébastien Apcher, et al.
RNA (New York, N.Y.)|September 16, 2025
The codon context provides <i>cis</i>-acting immune evasion for the human papilloma virus (HPV) E6Aikaterini Thermou, Chrysoula Daskalogianni, Lixiao Wang, et al.
Genes|September 5, 2019
Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune EvasionGaëlle Angrand, Alicia Quillévéré, Nadège Loaëc, et al.
Nucleic Acids Research|January 10, 2019
Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptidesRodrigo Prado Martins, Laurence Malbert-Colas, María José Lista, et al.
Disease Models & Mechanisms|January 20, 2019
A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defectsThomas Delerue, Déborah Tribouillard-Tanvier, Marlène Daloyau, et al.
Plos One|April 24, 2008
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prionsDéborah Tribouillard-Tanvier, Vincent Béringue, Nathalie Desban, et al.
The Journal of Biological Chemistry|May 16, 2013
The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competitionYanhong Pang, Sriram Kurella, Cécile Voisset, et al.
Nature Biotechnology|August 12, 2003
Isolation of drugs active against mammalian prions using a yeast-based screening assayStéphane Bach, Nicolas Talarek, Thibault Andrieu, et al.
Microbial Cell (Graz, Austria)|September 16, 2017
A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthinessMaría José Lista, Rodrigo Prado Martins, Gaelle Angrand, et al.
Disease Models & Mechanisms|February 22, 2014
A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virusCécile Voisset, Chrysoula Daskalogianni, Marie-Astrid Contesse, et al.
Pageof 8